NCT06253052

Brief Summary

The purpose of this study is to show if - compared to standard practice - allowing adults undergoing surgical procedures under anaesthesia care to drink clear fluids up to a volume of 200 ml between 2 h prior to the operation and the call to operation room (approximately 30 min prior to anaesthesia induction) will decrease patient thirst and increase patient satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
174

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 12, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

July 24, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2024

Completed
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

3 months

First QC Date

January 5, 2024

Last Update Submit

May 20, 2025

Conditions

Keywords

SurgeryPostoperative Nausea and VomitingDeliriumDehydrationSatisfaction, PatientHeadache

Outcome Measures

Primary Outcomes (1)

  • Thirst

    At any stage after your hospital admission have you had the following: Thirst (No/ Yes, moderate/ Yes, severe)

    Prior to induction of anaesthesia

Secondary Outcomes (17)

  • Total number of protocol deviations per group

    From enrollment until last Follow-up is concluded at up to 48 hours post surgery

  • Fluid fasting time

    Prior to induction of anesthesia

  • RASS

    2 hours after end of surgery

  • CAM-ICU

    2 hours after end of surgery

  • Headache

    Prior to induction of anesthesia and 2 hours after end of surgery

  • +12 more secondary outcomes

Study Arms (3)

Usual care

NO INTERVENTION

Fasting instructions as given by anaesthesiologist according to national guidelines (6 h solid meal and thick liquids, 2 h clear fluids).

Instructed guideline adherence

ACTIVE COMPARATOR

Patients should not involuntarily fast fluids for longer than 2 h.

Behavioral: Additional pre-OP-visit

Experimental intervention

EXPERIMENTAL

Patients should not involuntarily fast fluids for longer than 30 min.

Behavioral: Additional pre-OP-visitBehavioral: Liberal fasting regime

Interventions

OP-schedule is closely monitored and patients will be visited to support and encourage them in drinking clear fluids.

Experimental interventionInstructed guideline adherence

Patients may drink up to 200 ml clear fluids between 2 h prior to the surgery and the call to operation room.

Experimental intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (≥ 18 years)
  • American Society of Anesthesiologists (ASA) physical status classification I-III
  • Undergoing surgical procedure under anaesthesia care: general anaesthesia, regional anaesthesia, combined anaesthesia or monitored anaesthesia care.
  • The proportion of Patients undergoing general or combined anaesthesia is aimed to exceed 75%

You may not qualify if:

  • Absolute indication for rapid sequence induction including but not limited to:
  • Bowel obstruction including ileus
  • Stricture and oesophageal disorders including achalasia
  • Recent polytrauma or trauma of the upper gastrointestinal tract
  • Acute abdomen/peritonitis including active gastrointestinal bleeding
  • Relative indication for (modified) rapid sequence induction includes, but is not limited to:
  • Symptomatic gastroesophageal reflux disease, independent of food intake and persistent under medical treatment (PPI)
  • Hiatus hernia or upside down stomach
  • Upper gastrointestinal tumour
  • History of upper gastrointestinal surgery (oesophageal, gastric, duodenum, pancreatic)
  • Medically confirmed gastroparesis
  • Severe obesity, defined as body mass index ≥ 40 kg/m2
  • Dysphagia
  • Renal replacement therapy
  • Fluid restriction therapy
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wuerzburg University Hospital

Würzburg, Bavaria, 97080, Germany

Location

Related Publications (1)

  • Haas TE, Kranke P, Stegemann MN, Helmer P, Schmid B, Diehl FM, Heuschmann PU, Rucker V, Seitz AK, Diessner J, Heintel T, Saller T, Ruggeberg A, Kronert S, von Keitz J, Meybohm P. Benefits in adults allowed to drink clear liquids before anaesthesia until called to the operating room: A randomised pilot study. Eur J Anaesthesiol. 2025 Nov 19. doi: 10.1097/EJA.0000000000002309. Online ahead of print.

MeSH Terms

Conditions

Postoperative Nausea and VomitingDeliriumDehydrationPatient SatisfactionHeadache

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomitingConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesNeurocognitive DisordersMental DisordersWater-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic DiseasesTreatment Adherence and ComplianceHealth BehaviorBehaviorPain

Study Officials

  • Patrick Meybohm, Prof. Dr.

    University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany

    STUDY DIRECTOR
  • Tobias E Haas, Dr.

    University Hospital Würzburg, Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Oberdürrbacher Str. 6, 97080 Würzburg, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2024

First Posted

February 12, 2024

Study Start

July 24, 2024

Primary Completion

November 4, 2024

Study Completion

November 4, 2024

Last Updated

May 25, 2025

Record last verified: 2025-05

Locations